Navigation Links
Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia
Date:3/26/2012

ant improvement in tardive dyskinesia symptoms for the subjects while receiving the 50mg once-daily dose. These subjects had a significant reduction in tardive dyskinesia symptoms at the end of two weeks of active treatment vs. the end of two weeks of placebo (difference in LS mean of 4.2 for the 50mg period vs. the placebo period, p-value=0.002). As expected, the 12.5mg dosing group was not statistically better during the active treatment period than during the placebo period (difference in LS mean of 0.4 for the 12.5mg period vs. placebo period, p-value=0.68).

The improvement in symptomology is also evidenced by the significant improvement in AIMS scores over baseline levels relative to placebo, excluding the one site. NBI-98854 reduced the average baseline AIMS score by 9.2 points in the 50mg period (p-value=0.0004) vs. a reduction of 4.9 points in the 12.5mg period and 4.7 for the placebo periods. A responder analysis also showed improvement in both the investigator reported Clinical Global Impression-Tardive Dyskinesia and the patient reported Patient Global Impression of Change.

When including the data from the site in question, this study did not meet the pre-specified primary endpoint of reducing the AIMS scores during active treatment periods. The efficacy results from the entire study population showed a non-significant reduction in tardive dyskinesia at the end of two weeks of active treatment vs. the end of two weeks of placebo (difference in LS mean of 1.1 for the 50mg period vs. the placebo period (n=15), p-value=0.42) (difference in LS mean of 0.7 for the 12.5mg period vs. placebo period (n=17), p-value=0.59).

The tables below summarize the primary endpoint as well as the responder analyses for all clinical sites as well as the post-hoc analysis. All Clinical Trial Sites Baseline(mean)Placebo12.5mg50mgAbnormal Involuntary Movement Scale (LS Means)14.7

9.9

9.1

8.8 

 


'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
2. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
3. Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.
4. Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
6. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2015)... 2015 Nihon University is pleased to ... Medical-Engineering Collaboration "Medicine Definitely Jumps Up with 8K" ... Tokyo, Japan . Many experts ... will present their achievements and future prospects on ... produced with 8K technology. (Documentation: ...
(Date:7/4/2015)... BARCELONA, Spain , July 4, 2015 /PRNewswire/ ... to first-line chemotherapy for patients with unresectable metastatic ... Progression-Free Survival in that organ Patients ... spread only to the liver experienced the greatest ... from the addition of SIR-Spheres Y-90 resin microspheres ...
(Date:7/3/2015)... -- According to a new market ... Market ECG, Implantable Loop Recorder, Manual Event Monitor, ... Chamber Pacemaker, CRT-D, CRT-P - Global Forecast to ... (CM) and Cardiac Rhythm Management (CRM) Devices Market ... from $21,137.7 Million in 2015, at a CAGR ...
Breaking Medicine Technology:Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4
... MASI ) announced today that it will release third quarter ... the market closes on November 2, 2010. A conference ... (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman ... President and Chief Financial Officer. A live webcast of ...
... ENDP ) will announce its third quarter 2010 ... conference call and webcast at 10:00 a.m. ET that day ... president and CEO of Endo, Julie McHugh, chief operating officer, ... executive vice president and chief financial officer and Blaine Davis, ...
Cached Medicine Technology:Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010 2Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010 3Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010 2
(Date:7/6/2015)... ... 2015 , ... Acara Partners, a leading business team in ... complimentary educational webinar series for the summer of 2015. Learn ... clients through targeted marketing, sales, digital communications, branding and business development programs. The ...
(Date:7/6/2015)... ... 06, 2015 , ... Olive Fertility Centre is proud to announce that Olive ... on behalf of the department of Family Practice. , “This award is a real ... in. The technology is changing so rapidly and we are also developing new models ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network ... caregivers and medical professionals to chat with the CHN patient services team and ... a cancer diagnosis is often the most traumatic experience of a person’s life,” ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing ... newly constructed urgent care center will serve residents and visitors in the Cutler Bay ... MD Now’s 22nd South Florida location, the new facility will be the fourth to ...
(Date:7/6/2015)... ... 2015 , ... World renowned Los Angeles facial plastic surgeon , Dr. ... comprehensive treatment solutions. Individuals that want to make multiple changes to their facial appearance ... resolves each of their needs. , "Anytime I see an opportunity to change ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... Center basic scientists Roger Brent, Ph.D., a systems biologist, ... have been elected fellows of the American Association for ... fellow is an honor bestowed upon AAAS members by ... Center,s Basic Sciences Division, is being honored "for outstanding ...
... Cambridge, MASS. -- Researchers at MIT and Brigham and Women,s ... cisplatin much more effectively and safely in a form that ... cells and is activated once it reaches its target. ... shrink tumors in mice, using only one-third the amount of ...
... By Randy Dotinga HealthDay Reporter , TUESDAY, Jan. ... change your kid,s attitude: The most optimistic adolescents may be ... Researchers also have found a slight link between optimism ... are caveats. The new research, on kids in Australia, doesn,t ...
... Reporter , TUESDAY, Jan. 11 (HealthDay News) -- After ... are "special," today,s young people crave these boosts to ... new research suggests. The self-esteem movement of recent ... success and praise in a world that won,t necessarily ...
... Jan. 11, 2011 An international team of researchers ... human papillomavirus that one day may aid in the ... Led by researcher Per Jemth of Uppsala University in ... Journal of Biological Chemistry how an offensive ...
... brachytherapy has advantages compared to other therapy options in men ... in this respect. This is the result of a report ... Care (IQWiG) on 11 January 2011. In this report IQWiG ... completed in 2007. However, it was shown that no relevant ...
Cached Medicine News:Health News:Roger Brent and Robert Eisenman named AAAS fellows 2Health News:Delivering a potent cancer drug with nanoparticles can lessen side effects 2Health News:Delivering a potent cancer drug with nanoparticles can lessen side effects 3Health News:Optimism Could Help Kids Keep Depression at Bay 2Health News:For College Students, Praise May Trump Sex and Money 2Health News:For College Students, Praise May Trump Sex and Money 3Health News:Study details how protein made by HPV teams up on and thwarts protective human protein 2Health News:Study details how protein made by HPV teams up on and thwarts protective human protein 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 4
... The VersaPulse PowerSuite holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
... to quickly deliver up to 250 millijoules ... powerful single-pulse ablation. This type of high-energy ... and cleanest CO2 surgical laser available today. ... the independent adjustment of pulse energy and ...
... facial skin treatment, vascular treatment, ... Incorporates a wide range of ... hand pieces and large spot ... most flexibility. Compact table-top ...
... 435 is a full system for hair removal, ... up a complete hair reduction system. The ... heating of the hair bulb and bugle. To ... distributed to the tissue through the MedArt® 413 ...
Medicine Products: